Fulgent Genetics, Inc.

Healthcare

NASDAQ:FLGT · NASDAQ Global Market

Market Cap $533.36M Beta 0.92 P/E (TTM) -7.8

$18.68 -0.53%

-$0.10 today

52W Low $13.46High $31.04

Vol 0.22M · Avg 0.58M

EPS (TTM)-$2.39

Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-9.71%

Period High

$30.85

Period Low

$13.79

Latest

$18.68

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Butterfly Network, Inc.

NYSE:BFLY

$1.45B

CareDx, Inc

NASDAQ:CDNA

$1.19B

Personalis, Inc.

NASDAQ:PSNL

$851.63M

Castle Biosciences, Inc.

NASDAQ:CSTL

$627.83M

Valneva SE

NASDAQ:VALN

$507.78M

Arvinas, Inc.

NASDAQ:ARVN

$489.07M

Myriad Genetics, Inc.

NASDAQ:MYGN

$408.96M

Pacific Biosciences of California, Inc.

NASDAQ:PACB

$406.89M

Anavex Life Sciences Corp.

NASDAQ:AVXL

$231.68M

DarioHealth Corp.

NASDAQ:DRIO

$51.63M

What is the latest FLGT filing?

The latest filing shown is 8-K dated Jun 2, 2026.

How many recent filings does FLGT have?

Intrinsic Alpha currently shows 20 recent filings for FLGT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.